Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 11, 2009, Pages 1054-1061

  Li, Xiao Mei ^a   Ma, Yi Tong ^a   Yang, Yi Ning ^a   Liu, Fen ^a   Chen, Bang Dang ^a   Han, Wei ^a   Zhang, Jian Fa ^a   Gao, Xiao Ming ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Akt; Apoptosis; Extracellular signal regulated kinase 1 2; Glycogen synthase kinase 3 ; Left ventricular hypertrophy

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CALCIUM ATPASE 2A; DIGOXIGENIN; DNA NUCLEOTIDYLEXOTRANSFERASE; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; APOPTOSIS; ARTICLE; CATHETERIZATION; CELL SIZE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; ECHOCARDIOGRAPHY; ENDOPLASMIC RETICULUM; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE OVERLOAD; HEART VENTRICLE PRESSURE; HISTOLOGY; MALE; MOUSE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; SARCOPLASMIC RETICULUM; SHAM PROCEDURE; SURVIVAL; THICKNESS;

ANIMALS; AORTA; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FIBROSIS; GENE EXPRESSION; HEART FAILURE; HEMODYNAMICS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; ORGAN SIZE; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 70449477660     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05243.x     Document Type: Article

References (38)

1. Frey N, Olson EN. Cardiac hypertrophy: The good, the bad, and the ugly. Annu. Rev. Physiol. 2003 65 : 45 79.
2. Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease. J. Clin. Invest. 2007 117 : 568 575.
3. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol. Rev. 1999 79 : 215 262.
4. Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J. Am. Coll. Cardiol. 1998 32 : 1454 1459.
5. Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: A new therapeutic target? Circulation 2004 109 : 1580 1589.
6. Sugden PH. Signaling in myocardial hypertrophy: Life after calcineurin? Circ. Res. 1999 84 : 633 646.
7. Ding B, Price RL, Goldsmith EC et al. Left ventricular hypertrophy in ascending aortic stenosis mice: Anoikis and the progression to early failure. Circulation 2000 101 : 2854 2862.
8. Sun M, Chen M, Dawood F et al. Tumor necrosis factor-α mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation 2007 115 : 1398 1407.
9. Antos CL, McKinsey TA, Frey N et al. Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo. Proc. Natl Acad. Sci. USA 2002 99 : 907 912.
10. Aoki H, Richmond M, Izumo S, Sadoshima J. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro. Biochem. J. 2000 347 : 275 284.
11. Kacimi R, Gerdes AM. Alterations in G protein and MAP kinase signaling pathways during cardiac remodeling in hypertension and heart failure. Hypertension 2003 41 : 968 977.
12. Tang Q, Cai J, Shen D et al. Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3β signaling. J. Mol. Med. 2009 87 : 249 260.
13. De Acetis M, Notte A, Accornero F et al. Cardiac overexpression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload. Circ. Res. 2005 96 : 1087 1094.
14. Gao XM, Kiriazis H, Moore XL et al. Regression of pressure overload-induced left ventricular hypertrophy in mice. Am. J. Physiol. Heart Circ. Physiol. 2005 288 : H2702 7.
15. Yang Y, Ma Y, Han W et al. Age-related differences in postinfarct left ventricular rupture and remodeling. Am. J. Physiol. Heart Circ. Physiol. 2008 294 : H1815 22.
16. Manabe I, Shindo T, Nagai R. Gene expression in fibroblasts and fibrosis: Involvement in cardiac hypertrophy. Circ. Res. 2002 91 : 1103 1113.
17. Schnee JM, Hsueh WA. Angiotensin II, adhesion, and cardiac fibrosis. Cardiovasc. Res. 2000 46 : 264 268.
18. Burnett JC Jr., Kao PC, Hu DC et al. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 1986 231 : 1145 1147.
19. Mukoyama M, Nakao K, Saito Y et al. Increased human brain natriuretic peptide in congestive heart failure. N. Engl. J. Med. 1990 323 : 757 758. (Pubitemid 20288962)
20. Gupta MP. Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure. J. Mol. Cell. Cardiol. 2007 43 : 388 403.
21. 2+ homeostasis and cardiac contractility. J. Mol. Cell. Cardiol. 2001 33 : 1053 1063.
22. Miyata S, Minobe W, Bristow MR, Leinwand LA. Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ. Res. 2000 86 : 386 390.
23. 2+ load in human heart failure. Basic Res. Cardiol. 2002 97 (Suppl. I 163 171.
24. Condorelli G, Morisco C, Stassi G et al. Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. Circulation 1999 99 : 3071 3078.
25. Nishida K, Yamaguchi O, Hirotani S et al. p38α mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload. Mol. Cell. Biol. 2004 24 : 10611 10620.
26. Bueno OF, Molkentin JD. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ. Res. 2002 91 : 776 781.
27. Fischer P, Hilfiker-Kleiner D. Survival pathways in hypertrophy and heart failure: The gp130-STAT3 axis. Basic Res. Cardiol. 2007 102 : 279 297. (Pubitemid 46909707)
28. Ceci M, Gallo P, Santonastasi M et al. Cardiac-specific overexpression of E40K active Akt prevents pressure overload-induced heart failure in mice by increasing angiogenesis and reducing apoptosis. Cell Death Differ. 2007 14 : 1060 1062.
29. Brancaccio M, Fratta L, Notte A et al. Melusin, a muscle-specific integrin β1-interacting protein, is required to prevent cardiac failure in response to chronic pressure overload. Nat. Med. 2003 9 : 68 75.
30. Gonzalez A, Ravassa S, Loperena I et al. Association of depressed cardiac gp130-mediated antiapoptotic pathways with stimulated cardiomyocyte apoptosis in hypertensive patients with heart failure. J. Hypertens. 2007 25 : 2148 2157.
31. Purcell NH, Wilkins BJ, York A et al. Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo. Proc. Natl Acad. Sci. USA 2007 104 : 14074 14079.
32. Das A, Xi L, Kukreja RC. Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3β. J. Biol. Chem. 2008 283 : 29572 29585.
33. Baines CP, Zhang J, Wang GW et al. Mitochondrial PKCη and MAPK form signaling modules in the murine heart: Enhanced mitochondrial PKCη-MAPK interactions and differential MAPK activation in PKCη-induced cardioprotection. Circ. Res. 2002 90 : 390 397.
34. Valks DM, Cook SA, Pham FH, Morrison PR, Clerk A, Sugden PH. Phenylephrine promotes phosphorylation of Bad in cardiac myocytes through the extracellular signal-regulated kinases 1/2 and protein kinase A. J. Mol. Cell. Cardiol. 2002 34 : 749 763.
35. de Jager T, Pelzer T, Muller-Botz S, Imam A, Muck J, Neyses L. Mechanisms of estrogen receptor action in the myocardium. Rapid gene activation via the ERK1/2 pathway and serum response elements. J. Biol. Chem. 2001 276 : 27873 27880.
36. Jankowski M, Rachelska G, Donghao W, McCann SM, Gutkowska J. Estrogen receptors activate atrial natriuretic peptide in the rat heart. Proc. Natl Acad. Sci. USA 2001 98 : 11765 11770.
37. Adderley SR, Fitzgerald DJ. Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2. J. Biol. Chem. 1999 274 : 5038 5046.
38. Kemi OJ, Ceci M, Wisloff U et al. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy. J. Cell. Physiol. 2008 214 : 316 321.